PharmaVault
گنجینه اطلاعات داروسازی
The Pharmaceutical Information Vault
Excipient monograph · مونوگراف ماده جانبی
pharmavault.ir
Fructose
فروکتوز
1Nonproprietary names
- BPFructose
- JPFructose
- Ph. Eur.Fructose
- USP–NFFructose
2Synonyms and trade names
Advantose FS 95; D-arabino-2-hexulose; fructosum; fruit sugar; laevulose; levulose
3Chemical name and CAS Registry Number
D-(−)-Fructopyranose · [57-48-7]
4Empirical formula and molecular weight
C6H12O6 · 180.16
5Functional category
Sweetening agent, Diluent (filler)
Typical concentrations: — · Dosage forms: Solid, Liquid
6Applications in pharmaceutical formulation
Used as a sweetener and flavour enhancer in tablets, syrups and oral solutions; it is sweeter than sucrose (about 1.2–1.8 times, depending on temperature and pH) and enhances fruit flavours. Directly compressible grades are used as tablet diluents, particularly in chewable tablets. It is also used widely in foods and beverages.
7Description
A ketohexose monosaccharide occurring naturally in fruit and honey. Colourless crystals or a white crystalline powder, odourless and with a very sweet taste.
8Typical properties
- Melting point
- about 102–105 °C, with decomposition
- Specific rotation
- about −91° to −93.5° (at equilibrium, anhydrous basis)
- Solubility
- very soluble in water; soluble in ethanol and methanol
- Hygroscopicity
- hygroscopic; absorbs significant moisture at high relative humidity
- Relative sweetness
- about 1.2–1.8 × sucrose
9Stability and storage conditions
Hygroscopic; store in an airtight container in a cool, dry place. Fructose is most stable in solution at about pH 3–4. On heating, particularly in acid or alkaline conditions, it decomposes and browns, forming 5-hydroxymethylfurfural.
10Incompatibilities
As a reducing sugar it undergoes Maillard reactions with amines and amino acids. Incompatible with strong acids and alkalis, which cause browning, and with oxidising agents.
11Method of manufacture
Produced from sucrose by hydrolysis to invert sugar and separation of fructose from glucose, or from glucose (from starch) by enzymatic isomerisation followed by chromatographic separation; it is then crystallised. It can also be obtained by hydrolysis of inulin.
12Safety
Fructose is absorbed more slowly than glucose and is metabolised largely in the liver; it provides the same energy as other sugars. It must be avoided in patients with hereditary fructose intolerance, and large oral doses can cause flatulence, abdominal pain and diarrhoea. It is no longer recommended as a sugar substitute for diabetic patients, and intravenous use has been associated with lactic acidosis.
13Handling precautions
Observe normal precautions for the quantity handled. Avoid generating dust; eye protection is recommended.
14Regulatory status
GRAS listed. Included in the FDA Inactive Ingredient Database (oral preparations) and in non-parenteral medicines licensed in Europe.
15Related substances
Dextrose; high-fructose corn syrup; invert sugar; sucrose.
16Comments
Because of its hygroscopicity, tablets containing fructose should be made and packed under low-humidity conditions. Its sweetness is greatest in cold, slightly acidic solutions and falls as the temperature rises.